THE IMPORTANCE

OF NEUROFEEDBACK

TREATMENT IN DEPRESSION

WEBINAR RECORDING

Presenter: Dr. Tanju Surmeli

Neurofeedback has been used successfully in numerous cases of ADHD, depression, anxiety and mTBI. Learn the fundamentals of biomarkers findings in some psychiatric illnesses (Depression, vs Bipolar Disorder, Dementia,Anxiety Disorders, and mTBI) and be able to recognize characteristic marker analysis before neurofeedback treatment and during neurofeedback treatment. Develop a rationale intervention based on this assessment data which develops baseline NF treatment protocols for personalized medicine treatment model in depression.

Learning Objectives:

• To be able to use one of the non-medication treatments for Depression such as neurofeedback.
• If depression patients don’t get better with medication or other treatments, to learn more effective ways of treating depression.
• Learn how to use neurofeedback as a therapeudic tool.

All views expressed in the recording are solely those of the presenters and participants.

About Dr. Tanju Surmeli

Dr. Tanju Sürmeli received his Medical Doctor degree from Dokuz Eylül University in Izmir, Turkey. He completed Postgraduate training at the Global Clinical Scholars Research Training Program at Harvard Medical School and the Research Fellowship in EEG and Psychopharmacology at New York Medical College and the residency training in Psychiatry and Neurology at University of Connecticut/Institute of Living, Yale, and University of Texas, San Antonio. He is a board certified psychiatrist and founder and director of the Healthy Living Center for Research and Education and the founder of the Biofeedback, Neurofeedback and QEEG/ERP use in Psychiatry Foundation in Istanbul, Turkey. As well as having numerous memberships and teaching positions in international medical societies he is also a reviewer for the numerous prestigious journals. He is the prev’ious president of the International Quantitative Board of Electrophysiology in US and was a Board member for the International Society for Neurofeedback and Research in US and Board member for the Society of Applied Neuroscience in UK. His Schizophrenia Case Study paper was awarded as a publication that, “in its consideration, has most significantly advanced the field of Neurofeedback in 2013”. Author of textbooks or chapters on Psychiatry, QEEG and Neurofeedback, and papers published in International Journals. His Research Interests includes QEEG, Neurofeedback in Depression, MCI, Alzheimer’s Disease, Vasculer Dementia, Down Syndrome, Mental Disability and Schizophrenia. He took part in the Turkey branch of the European Union's COST B27 proposal for the Electric Neuronal Oscillations (ENOC) and Cognition action program.